Results 111 to 120 of about 464 (144)

FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021-2025): Pharmaceutical Use, Trends and Synthetic Approaches. [PDF]

Medicines (Basel)
Benedetto Tiz D.
europepmc   +1 more source

<i>Demodex folliculorum</i>. [PDF]

Diagnostics (Basel)
Khan AZ, Fineide F, Wohlmann J, Gundersen KG, Gundersen M, Kolko M, Utheim TP.   +6 more
europepmc   +1 more source

Evaluation of efficacy and pharmacokinetics of novel fluralaner tablet formulation (WellPet™) in dogs. [PDF]

Front Vet Sci
Cruz BC, Teixeira MB, de Melo Cruz GA, da Silva JADCEM, Michels MG, Pistoni CDN, Buso MAM, de Almeida FN, Gatto IRH.   +8 more
europepmc   +1 more source

A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis. [PDF]

Cureus
Awan B, Elsaigh M, Tariq A, Badee M, Loomba A, Khedr Y, Abdelmaksoud A.   +6 more
europepmc   +1 more source

[Simultaneous identification and detection of four novel isoxazoline drugs in bovine-origin foods using ultra-high performance liquid chromatography coupled to quadrupole/linear ion trap mass spectrometry]. [PDF]

Se Pu
Yang C, Zhu WX, Liu YF, Wei W, Zhao F, Hu K, Zhao WJ.   +6 more
europepmc   +1 more source

Field efficacy assessment of a combination of afoxolaner, moxidectin and pyrantel pamoate to treat dogs naturally infested with Sarcoptes scabiei. [PDF]

Parasite
Antoine L, Papadopoulos E, Sioutas G, Tan DY, Madder M, Tielemans E.   +5 more
europepmc   +1 more source

Demodex and the eye - A review. [PDF]

Indian J Ophthalmol
Chatterjee S, Gupta J, Srinivas SP, Rao SK.   +3 more
europepmc   +1 more source

Correction: Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use

Drugs & Therapy Perspectives
openaire   +1 more source

Single-dose lotilaner efficacy for notoedric mange in domestic cats under tropical conditions

International Journal of Applied Research
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lotilaner for Demodex Blepharitis: The Journey From Veterinary Use to Human Medicine

Journal of Ocular Pharmacology and Therapeutics
In 2023, Xdemvy® (0.25% lotilaner ophthalmic solution) was approved by the U.S. FDA for treating Demodex blepharitis in humans. This article reviews lotilaner's history, physicochemical properties, pharmacokinetics, pharmacology, clinical outcomes, and other indications for which it is being evaluated clinically.
Akanksha Sharma, Uday B Kompella
exaly   +3 more sources